Wendy Heywood awarded an MRC UCL confidence in concept award

14 Dec 2016, 10:09 a.m.

GOSH BRC-funded, Senior research associate, Dr Wendy Heywood has been awarded £98,000 from the UCL Confidence in Concept fund to develop newly discovered biomarkers for disease stratification of mucopolysaccharidosis (MPS) into a clinical assay for validation.

Earlier in the year we reported the publication of new urine markers for downstream disease pathology features of patients with MPS that could be used for early disease phenotyping and treatment monitoring. This work has now led to further funding for these markers to be developed to clinical translation.

New 'Secure Data Environment' joint offering from GOSH and Aridhia to accelerate clinical research and healthcare innovation

We are expanding our partnership with Aridhia to include an offer to external partners.

Join us in the countdown to Rare Disease Day 2025

Rare Disease Day takes place annually on the last day of February and is a global opportunity to increase awareness and advocate for those living with rare conditions.

Could adapting our sinks help combat superbugs?

Discover how a Consultant Microbiologist at GOSH turned an innovative idea into a patented product that could revolutionise infection control in hospitals, schools, and airports – helping to stop superbugs like MRSA.

GOSH pilots AI tool to give clinicians more quality-time with patients

Patients and clinicians at GOSH have been taking part in the first NHS trial of a bespoke healthcare AI assistant, TORTUS, to help increase face-to-face time during appointments.